Figure 6.
Changes in peripheral blood basophils during omalizumab treatment (mean, SEM). A: Peripheral blood basophils. B: FcεRI expression. C: IgE expression. (* p<0.05, **p<0.01, and ***p<0.001; NS, not significant).). D, day; W, week
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.